After helping to transform NYU Langone into one of the most prestigious academic medical centers in the U.S., Dr. Robert I. Grossman is hanging up his hat as CEO in August 2025.

The news, according to the New York Post, was shared internally via an email to NYU Langone staffers.

"It is immensely gratifying to know that we have transformed NYU Langone Health into an institution that is simply nonpareil,” Grossman said in the message.

Home Depot co-founder and billionaire Ken Langone, the chair of NYU Langone’s board of trustees, will be retiring alongside Grossman in 2025. While Fiona Duckenmiller will reportedly replace Langone as chair of the board of trustees, a successor for Grossman as CEO has not yet been determined.

Innovation has been a hallmark of Dr. Grossman’s leadership of NYU Langone and NYU Grossman School of Medicine since his tenure began in 2007. This includes establishing an accelerated three-year MD pathway for select medical students, making NYU Grossman School of Medicine the first nationally ranked medical school to enable medical students to graduate in three years.

More recently, Dr. Grossman was the driving force behind the creation of NYU Grossman Long Island School of Medicine — a partnership between NYU and NYU Langone — the only medical school in the U.S. that offers a three-year M.D. degree focused on primary care and full-tuition scholarships. In July 2023, the school was renamed in honor of Dr. Grossman’s leadership.

In collaborations with the Board of Trustees and institutional leadership, Grossman oversaw an increase in NYU Langone’s revenue from $2 billion in 2007 to more than $12 billion in 2023, including more than $4.9 billion in philanthropy since 2007. NYU Langone’s research awards from the National Institutes of Health (NIH) have grown from $129 million to over $800 million.

NYU Langone currently employs more than 48,000 people, including over 12,000 clinicians, stretching across six inpatient facilities and over 300 locations throughout the New York City region and in Florida.

Grossman received his bachelor’s degree in biology from Tulane University and his medical degree from the University of Pennsylvania, where he was elected to Alpha Omega Alpha. He completed his internship at Beth Israel Hospital in Boston, two years of a neurosurgery residency at the University of Pennsylvania, a radiology residency at the University of Pennsylvania, and a two-year fellowship in neuroradiology at Massachusetts General Hospital. He is board-certified in radiology and neuroradiology.

Back to HCB News

Business Affairs Homepage